These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 25811961

  • 21. A mitochondria-targeting hetero-binuclear Ir(iii)-Pt(ii) complex induces necrosis in cisplatin-resistant tumor cells.
    Ouyang C, Chen L, Rees TW, Chen Y, Liu J, Ji L, Long J, Chao H.
    Chem Commun (Camb); 2018 Jun 14; 54(49):6268-6271. PubMed ID: 29850704
    [Abstract] [Full Text] [Related]

  • 22. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C, Bettio F, Baccichetti F, Trevisan A, Giovagnini L, Fregona D.
    Chem Biol Interact; 2004 Jun 30; 148(1-2):37-48. PubMed ID: 15223355
    [Abstract] [Full Text] [Related]

  • 23. The in vitro renal cell toxicity of some unconventional anticancer phenanthroline-based platinum(II) complexes.
    Ng NS, Wu MJ, Myers SJ, Aldrich-Wright JR.
    J Inorg Biochem; 2018 Feb 30; 179():97-106. PubMed ID: 29197671
    [Abstract] [Full Text] [Related]

  • 24. Studies on the activity of two Trans-planaramine platinum(II) complexes coded as DH4 and DH5 in human ovarian tumour models.
    Deqnah N, Yu JQ, Beale P, Huq F.
    Anticancer Res; 2012 Dec 30; 32(12):5331-6. PubMed ID: 23225434
    [Abstract] [Full Text] [Related]

  • 25. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI, Kim JH, Lee KT, Choi JH.
    Gynecol Oncol; 2011 Dec 30; 123(3):588-96. PubMed ID: 21945308
    [Abstract] [Full Text] [Related]

  • 26. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
    Tayyem H, Huq F, Yu JQ, Beale P, Fisher K.
    ChemMedChem; 2008 Jan 30; 3(1):145-51. PubMed ID: 17963210
    [Abstract] [Full Text] [Related]

  • 27. Lipophilic Pt(II) complexes with selective efficacy against cisplatin-resistant testicular cancer cells.
    Biersack B, Dietrich A, Zoldakova M, Kalinowski B, Paschke R, Schobert R, Mueller T.
    J Inorg Biochem; 2011 Dec 30; 105(12):1630-7. PubMed ID: 22071088
    [Abstract] [Full Text] [Related]

  • 28. A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
    Shahsavar F, Bozorgmehr M, Mirzadegan E, Abedi A, Lighvan ZM, Mohammadi F, Safari N, Amani V, Zarnani AH.
    Anticancer Agents Med Chem; 2016 Dec 30; 16(3):393-403. PubMed ID: 26899296
    [Abstract] [Full Text] [Related]

  • 29. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A, Horváth V, Svihálková-Sindlerová L, Soucek K, Hofmanová J, Sova P, Kroutil A, Zák F, Mistr A, Turánek J.
    Biochem Pharmacol; 2005 Feb 01; 69(3):373-83. PubMed ID: 15652229
    [Abstract] [Full Text] [Related]

  • 30. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G, Kishimoto S, Manorek G, Breaux JK, Howell SB.
    Cancer Chemother Pharmacol; 2007 Feb 01; 59(3):301-12. PubMed ID: 16770583
    [Abstract] [Full Text] [Related]

  • 31. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
    Fokkema E, Groen HJ, Helder MN, de Vries EG, Meijer C.
    Biochem Pharmacol; 2002 Jun 01; 63(11):1989-96. PubMed ID: 12093475
    [Abstract] [Full Text] [Related]

  • 32. Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models.
    Deqnah N, Qing Yu J, Beale P, Fisher K, Huq F.
    Med Chem; 2013 Jun 01; 9(4):539-44. PubMed ID: 23061563
    [Abstract] [Full Text] [Related]

  • 33. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
    Pang SK, So WK, Ho YP, Au-Yeung CF.
    Anticancer Agents Med Chem; 2014 Jun 01; 14(5):756-61. PubMed ID: 24476313
    [Abstract] [Full Text] [Related]

  • 34. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
    Łakomska I, Hoffmann K, Wojtczak A, Sitkowski J, Maj E, Wietrzyk J.
    J Inorg Biochem; 2014 Dec 01; 141():188-197. PubMed ID: 25277461
    [Abstract] [Full Text] [Related]

  • 35. Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and -resistant human ovarian cancer cells.
    Marverti G, Ligabue A, Montanari M, Guerrieri D, Cusumano M, Di Pietro ML, Troiano L, Di Vono E, Iotti S, Farruggia G, Wolf F, Monti MG, Frassineti C.
    Invest New Drugs; 2011 Feb 01; 29(1):73-86. PubMed ID: 19834646
    [Abstract] [Full Text] [Related]

  • 36. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
    Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young RC, Ozols RF.
    Cancer Res; 1987 Jan 15; 47(2):414-8. PubMed ID: 3539322
    [Abstract] [Full Text] [Related]

  • 37. Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.
    Perego P, Gatti L, Righetti SC, Beretta GL, Carenini N, Corna E, Dal Bo L, Tinelli S, Colangelo D, Leone R, Apostoli P, Lombardi L, Beggiolin G, Piazzoni L, Zunino F.
    Int J Cancer; 2003 Jul 10; 105(5):617-24. PubMed ID: 12740909
    [Abstract] [Full Text] [Related]

  • 38. Synergism from combinations of tris(benzimidazole) monochloroplatinum(II) chloride with capsaicin, quercetin, curcumin and cisplatin in human ovarian cancer cell lines.
    Arzuman L, Beale P, Chan C, Yu JQ, Huq F.
    Anticancer Res; 2014 Oct 10; 34(10):5453-64. PubMed ID: 25275041
    [Abstract] [Full Text] [Related]

  • 39. Multiaction Pt(IV) Complexes: Cytotoxicity in Ovarian Cancer Cell Lines and Mechanistic Studies.
    Tabrizi L, M Jones A, Romero-Canelon I, Erxleben A.
    Inorg Chem; 2024 Aug 12; 63(32):14958-14968. PubMed ID: 39083592
    [Abstract] [Full Text] [Related]

  • 40. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I, Ling YH, al-Baker S, Khokhar AR, Perez-Soler R.
    Cancer Res; 1993 Oct 15; 53(20):4913-9. PubMed ID: 8402681
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.